STEGLUJAN 100 mg/1

STEGLUJAN 100 mg/1 combines ertugliflozin and sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a comprehensive treatment plan.

STEGLUJAN 100 mg/1 is primarily used for managing type 2 diabetes in adults. It works by combining two active ingredients, ertugliflozin and sitagliptin, to help regulate blood sugar levels. This medication is often prescribed alongside diet and exercise to improve glycemic control. People often ask, 'What is STEGLUJAN used for?' and the answer is that it is designed to assist in the management of type 2 diabetes.

Common effects of STEGLUJAN 100 mg/1 may include urinary tract infections, hypoglycemia, and diarrhea. Some users might experience increased urination or symptoms of a cold. These effects can vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

STEGLUJAN 100 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions. Patients with a history of kidney issues or those on a low-sodium diet should discuss this medication with their healthcare provider. Proper storage and handling are essential to maintain the medication's efficacy.

STEGLUJAN 100 mg/1 may interact with certain medications, including insulin, other diabetes drugs, and diuretics. Alcohol consumption should be moderated, as it can affect blood sugar levels. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.